{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:26:26Z","timestamp":1769919986860,"version":"3.49.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,8,5]],"date-time":"2010-08-05T00:00:00Z","timestamp":1280966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10067-010-1544-x","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T06:16:18Z","timestamp":1280902578000},"page":"1345-1351","source":"Crossref","is-referenced-by-count":30,"title":["Antibodies against cyclic citrullinated peptides in infectious diseases\u2014a systematic review"],"prefix":"10.1007","volume":"29","author":[{"given":"Isabella","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mittermayer","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,5]]},"reference":[{"issue":"8","key":"1544_CR1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/rheumatology\/33.8.735","volume":"33","author":"DP Symmons","year":"1994","unstructured":"Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ (1994) The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 33(8):735\u2013739","journal-title":"Br J Rheumatol"},{"key":"1544_CR2","first-page":"169","volume":"33","author":"JF Marques Neto","year":"1993","unstructured":"Marques Neto JF (1993) Estudo multicentrico da preval\u00eancia da artrite reumat\u00f3ide do adulto em amostra da popula\u00e7\u00e3o brasileira. Rev Bras Reumatol 33:169\u2013173","journal-title":"Rev Bras Reumatol"},{"issue":"3","key":"1544_CR3","first-page":"594","volume":"31","author":"ER Senna","year":"2004","unstructured":"Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM et al (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31(3):594\u2013597","journal-title":"J Rheumatol"},{"issue":"3","key":"1544_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1544_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","volume":"2","author":"R Goldbach-Mansky","year":"2000","unstructured":"Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2(3):236\u2013243","journal-title":"Arthritis Res"},{"issue":"1","key":"1544_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1):155\u2013163","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1544_CR7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-152-7-201004060-00010","volume":"152","author":"PF Whiting","year":"2010","unstructured":"Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M et al (2010) Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 152(7):456\u2013464","journal-title":"Ann Intern Med"},{"issue":"1","key":"1544_CR8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10067-007-0656-4","volume":"27","author":"M Santiago","year":"2008","unstructured":"Santiago M, Baron M, Miyachi K, Fritzler MJ, Bu-Hakima M, Leclercq S et al (2008) A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis. Clin Rheumatol 27(1):77\u201383","journal-title":"Clin Rheumatol"},{"issue":"8","key":"1544_CR9","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","volume":"56","author":"H Bang","year":"2007","unstructured":"Bang H, Egerer K, Gauliard A, Luthke K, Rudolph PE, Fredenhagen G et al (2007) Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 56(8):2503\u20132511","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1544_CR10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1373\/clinchem.2006.078063","volume":"53","author":"D Coenen","year":"2007","unstructured":"Coenen D, Verschueren P, Westhovens R, Bossuyt X (2007) Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem 53(3):498\u2013504","journal-title":"Clin Chem"},{"issue":"4","key":"1544_CR11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2009.108456","volume":"69","author":"L Damjanovska","year":"2010","unstructured":"Damjanovska L, Thabet MM, Levarth EW, Stoeken-Rijsbergen G, van der Voort EI, Toes RE et al (2010) Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis 69(4):730\u2013732","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1544_CR12","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/ar2008","volume":"8","author":"C Dejaco","year":"2006","unstructured":"Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 8(4):R119","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1544_CR13","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.3899\/jrheum.081263","volume":"36","author":"R Engelmann","year":"2009","unstructured":"Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, Neeck G et al (2009) The anti-mutated citrullinated vimentin response classifies patients with rheumatoid arthritis into broad and narrow responders. J Rheumatol 36(12):2670\u20132674","journal-title":"J Rheumatol"},{"issue":"6","key":"1544_CR14","first-page":"1002","volume":"35","author":"L Innala","year":"2008","unstructured":"Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR (2008) Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24\u00a0months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol 35(6):1002\u20131008","journal-title":"J Rheumatol"},{"issue":"3","key":"1544_CR15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/092986608783744153","volume":"15","author":"G Keskin","year":"2008","unstructured":"Keskin G, Inal A, Keskin D, Pekel A, Baysal O, Dizer U et al (2008) Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis. Protein Pept Lett 15(3):314\u2013317","journal-title":"Protein Pept Lett"},{"issue":"6","key":"1544_CR16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.080796","volume":"36","author":"X Liu","year":"2009","unstructured":"Liu X, Jia R, Zhao J, Li Z (2009) The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol 36(6):1136\u20131142","journal-title":"J Rheumatol"},{"issue":"1","key":"1544_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/art.23188","volume":"58","author":"L Mathsson","year":"2008","unstructured":"Mathsson L, Mullazehi M, Wick MC, Sjoberg O, van Vollenhoven R, Klareskog L et al (2008) Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 58(1):36\u201345","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1544_CR18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3899\/jrheum.080656","volume":"36","author":"N Mutlu","year":"2009","unstructured":"Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI (2009) Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol 36(3):491\u2013500","journal-title":"J Rheumatol"},{"issue":"6","key":"1544_CR19","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar2570","volume":"10","author":"RP Nicaise","year":"2008","unstructured":"Nicaise RP, Grootenboer MS, Bruns A, Hurtado M, Palazzo E, Hayem G et al (2008) Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Res Ther 10(6):R142","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1544_CR20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","volume":"34","author":"H Poulsom","year":"2008","unstructured":"Poulsom H, Charles PJ (2008) Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clin Rev Allergy Immunol 34(1):4\u201310","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1544_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00296-008-0614-8","volume":"29","author":"R Sghiri","year":"2008","unstructured":"Sghiri R, Bouajina E, Bargaoui D, Harzallah L, Fredj HB, Sammoud S et al (2008) Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatol Int 29(1):59\u201362","journal-title":"Rheumatol Int"},{"issue":"1","key":"1544_CR22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","volume":"62","author":"O Snir","year":"2010","unstructured":"Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S et al (2010) Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum 62(1):44\u201352","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1544_CR23","first-page":"1658","volume":"34","author":"L Soos","year":"2007","unstructured":"Soos L, Szekanecz Z, Szabo Z, Fekete A, Zeher M, Horvath IF et al (2007) Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. J Rheumatol 34(8):1658\u20131663","journal-title":"J Rheumatol"},{"issue":"2","key":"1544_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen SW, Goll GL, van der Heijde D, Landewe R, Lie BA, Odegard S et al (2010) Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 69(2):345\u2013351","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1544_CR25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","volume":"34","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz Z, Soos L, Szabo Z, Fekete A, Kapitany A, Vegvari A et al (2008) Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? Clin Rev Allergy Immunol 34(1):26\u201331","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1544_CR26","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar2362","volume":"10","author":"J Ursum","year":"2008","unstructured":"Ursum J, Nielen MM, van Schaardenburg SD, van der Horst AR, van de Stadt RJ, Dijkmans BA et al (2008) Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study. Arthritis Res Ther 10(1):R12","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"1544_CR27","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"MP Linden van der","year":"2009","unstructured":"van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW et al (2009) Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum 60(8):2232\u20132241","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1544_CR28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00296-009-0854-2","volume":"29","author":"E Wagner","year":"2009","unstructured":"Wagner E, Skoumal M, Bayer PM, Klaushofer K (2009) Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol Int 29(11):1315\u20131321","journal-title":"Rheumatol Int"},{"issue":"10","key":"1544_CR29","first-page":"159","volume":"106","author":"K Egerer","year":"2009","unstructured":"Egerer K, Feist E, Burmester GR (2009) The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens. Dtsch Arztebl Int 106(10):159\u2013163","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"1544_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","volume":"69","author":"JJ Luime","year":"2010","unstructured":"Luime JJ, Colin EM, Hazes JM, Lubberts E (2010) Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis 69(2):337\u2013344","journal-title":"Ann Rheum Dis"},{"key":"1544_CR31","author":"X Qin","year":"2010","unstructured":"Qin X, Deng Y, Xu J, Li TJ, Li S, Zhao JM (2010) Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis. Rheumatol Int. doi: 10.1007\/s00296-009-1343-3","journal-title":"Rheumatol Int"},{"key":"1544_CR32","first-page":"174","volume":"46","author":"AF da Silva","year":"2006","unstructured":"da Silva AF (2006) Valor diagn\u00f3stico do anticorpo antipept\u00eddeo citrulinado c\u00edclico na artrite reumat\u00f3ide. Rev Bras Reumatol 46:174\u2013180","journal-title":"Rev Bras Reumatol"},{"issue":"8","key":"1544_CR33","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2005.045229","volume":"65","author":"O Elkayam","year":"2006","unstructured":"Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65(8):1110\u20131112","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1544_CR34","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar2913","volume":"12","author":"O Elkayam","year":"2010","unstructured":"Elkayam O, Segal R, Bendayan D, van Uitert R, Onnekink C, Pruijn GJ (2010) The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment. Arthritis Res Ther 12(1):R12","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"1544_CR35","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.23514","volume":"58","author":"P Kakumanu","year":"2008","unstructured":"Kakumanu P, Yamagata H, Sobel ES, Reeves WH, Chan EK, Satoh M (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58(6):1576\u20131581","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1544_CR36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10067-008-1035-5","volume":"28","author":"S Mori","year":"2009","unstructured":"Mori S, Naito H, Ohtani S, Yamanaka T, Sugimoto M (2009) Diagnostic utility of anti-cyclic citrullinated peptide antibodies for rheumatoid arthritis in patients with active lung tuberculosis. Clin Rheumatol 28(3):277\u2013283","journal-title":"Clin Rheumatol"},{"issue":"1","key":"1544_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2006.12.001","volume":"28","author":"AM Atta","year":"2007","unstructured":"Atta AM, Carvalho EM, Jeronimo SM, Sousa Atta ML (2007) Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody. J Autoimmun 28(1):55\u201358","journal-title":"J Autoimmun"},{"issue":"4","key":"1544_CR38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10067-007-0810-z","volume":"27","author":"LS Guedes-Barbosa","year":"2008","unstructured":"Guedes-Barbosa LS, Mangueira C, Scheinberg M (2008) Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association. Clin Rheumatol 27(4):515\u2013516","journal-title":"Clin Rheumatol"},{"issue":"11","key":"1544_CR39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1590\/S0100-879X2008001100010","volume":"41","author":"SL Ribeiro","year":"2008","unstructured":"Ribeiro SL, Pereira HL, Silva NP, Neves RM, Sato EI (2008) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Braz J Med Biol Res 41(11):1005\u20131010","journal-title":"Braz J Med Biol Res"},{"issue":"3","key":"1544_CR40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10067-009-1327-4","volume":"29","author":"MK Lim","year":"2010","unstructured":"Lim MK, Shim TS, Sheen DH, Na DJ, Min SS, Shim SC (2010) Anti-cyclic citrulline peptide antibody in non-tuberculous mycobacteria sera: a negative association. Clin Rheumatol 29(3):335\u2013336","journal-title":"Clin Rheumatol"},{"issue":"7","key":"1544_CR41","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1515\/CCLM.2009.189","volume":"47","author":"IH Bassyouni","year":"2009","unstructured":"Bassyouni IH, Ezzat Y, Hamdy S, Talaat RM (2009) Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection. Clin Chem Lab Med 47(7):842\u2013847","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"1544_CR42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/clinchem\/47.6.1089","volume":"47","author":"N Bizzaro","year":"2001","unstructured":"Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47(6):1089\u20131093","journal-title":"Clin Chem"},{"issue":"2","key":"1544_CR43","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/ar1041","volume":"6","author":"M Bombardieri","year":"2004","unstructured":"Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V et al (2004) Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 6(2):R137\u2013R141","journal-title":"Arthritis Res Ther"},{"key":"1544_CR44","author":"WM Ezzat","year":"2009","unstructured":"Ezzat WM, Raslan HM, Aly AA, Emara NA, El Menyawi MM, Edrees A (2009) Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy. Rheumatol Int. doi: 10.1007\/s00296-009-1225-8","journal-title":"Rheumatol Int"},{"issue":"1","key":"1544_CR45","first-page":"121","volume":"26","author":"T Koga","year":"2008","unstructured":"Koga T, Migita K, Miyashita T, Maeda Y, Nakamura M, Abiru S et al (2008) Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases. Clin Exp Rheumatol 26(1):121\u2013124","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1544_CR46","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10067-006-0451-7","volume":"26","author":"SI Lee","year":"2007","unstructured":"Lee SI, Yoo WH, Yun HJ, Kim DS, Lee HS, Choi SI et al (2007) Absence of antibody to cyclic citrullinated peptide in sera of non-arthritic patients with chronic hepatitis B virus infection. Clin Rheumatol 26(7):1079\u20131082","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1544_CR47","first-page":"489","volume":"32","author":"D Lienesch","year":"2005","unstructured":"Lienesch D, Morris R, Metzger A, Debuys P, Sherman K (2005) Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. J Rheumatol 32(3):489\u2013493","journal-title":"J Rheumatol"},{"issue":"4","key":"1544_CR48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3899\/jrheum.080653","volume":"36","author":"MK Lim","year":"2009","unstructured":"Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC (2009) Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. J Rheumatol 36(4):712\u2013716","journal-title":"J Rheumatol"},{"issue":"4","key":"1544_CR49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10067-007-0729-4","volume":"27","author":"FC Liu","year":"2008","unstructured":"Liu FC, Chao YC, Hou TY, Chen HC, Shyu RY, Hsieh TY et al (2008) Usefulness of anti-CCP antibodies in patients with hepatitis C virus infection with or without arthritis, rheumatoid factor, or cryoglobulinemia. Clin Rheumatol 27(4):463\u2013467","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1544_CR50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00296-009-0997-1","volume":"30","author":"E Orge","year":"2010","unstructured":"Orge E, Cefle A, Yazici A, Gurel-Polat N, Hulagu S (2010) The positivity of rheumatoid factor and anti-cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. Rheumatol Int 30(4):485\u2013488","journal-title":"Rheumatol Int"},{"issue":"1","key":"1544_CR51","first-page":"57","volume":"22","author":"A Riccio","year":"2008","unstructured":"Riccio A, Postiglione L, La DP, Spano A, Marzocchella C, Tarantino G (2008) Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. J Biol Regul Homeost Agents 22(1):57\u201361","journal-title":"J Biol Regul Homeost Agents"},{"key":"1544_CR52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1196\/annals.1313.033","volume":"1050","author":"U Sauerland","year":"2005","unstructured":"Sauerland U, Becker H, Seidel M, Schotte H, Willeke P, Schorat A et al (2005) Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann NY Acad Sci 1050:314\u2013318","journal-title":"Ann NY Acad Sci"},{"issue":"3","key":"1544_CR53","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2005.038042","volume":"65","author":"D Sene","year":"2006","unstructured":"Sene D, Ghillani-Dalbin P, Limal N, Thibault V, van Boekel T, Piette JC et al (2006) Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome. Ann Rheum Dis 65(3):394\u2013397","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1544_CR54","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/art.20355","volume":"50","author":"MH Wener","year":"2004","unstructured":"Wener MH, Hutchinson K, Morishima C, Gretch DR (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum 50(7):2305\u20132308","journal-title":"Arthritis Rheum"},{"key":"1544_CR55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","volume":"23","author":"RLF Nienhuis","year":"1964","unstructured":"Nienhuis RLF (1964) A new serum factor in patients with rheumatoid arthritis\u2014the antiperinuclear factor. Ann Rheum Dis 23:302\u2013305","journal-title":"Ann Rheum Dis"},{"issue":"16","key":"1544_CR56","first-page":"1063","volume":"42","author":"A Tursi","year":"1966","unstructured":"Tursi A, Liso V, Bonomo L (1966) Incidence and characteristics of the antiperinuclear factor in the blood of patients with rheumatoid arthritis and other diseases. Boll Soc Ital Biol Sper 42(16):1063\u20131065","journal-title":"Boll Soc Ital Biol Sper"},{"issue":"2","key":"1544_CR57","first-page":"82","volume":"27","author":"E Keil","year":"1972","unstructured":"Keil E, Heil G, Litze G, Seidel K (1972) Demonstration of an antiperinuclear factor in patients with rheumatic diseases, liver diseases and lung tuberculosis using fluorescence technic. Z Gesamte Inn Med 27(2):82\u201385","journal-title":"Z Gesamte Inn Med"},{"issue":"1","key":"1544_CR58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1172\/JCI117300","volume":"94","author":"MA Moscarello","year":"1994","unstructured":"Moscarello MA, Wood DD, Ackerley C, Boulias C (1994) Myelin in multiple sclerosis is developmentally immature. J Clin Invest 94(1):146\u2013154","journal-title":"J Clin Invest"},{"issue":"44)","key":"1544_CR59","doi-asserted-by":"crossref","first-page":"27893","DOI":"10.1074\/jbc.272.44.27893","volume":"272","author":"E Tarcsa","year":"1997","unstructured":"Tarcsa E, Marekov LN, Andreoli J, Idler WW, Candi E, Chung SI et al (1997) The fate of trichohyalin. Sequential post-translational modifications by peptidyl-arginine deiminase and transglutaminases. J Biol Chem 272(44)):27893\u201327901","journal-title":"J Biol Chem"},{"issue":"5","key":"1544_CR60","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1523-1747.2003.12138.x","volume":"120","author":"Y Tsuji","year":"2003","unstructured":"Tsuji Y, Akiyama M, Arita K, Senshu T, Shimizu H (2003) Changing pattern of deiminated proteins in developing human epidermis. J Invest Dermatol 120(5):817\u2013822","journal-title":"J Invest Dermatol"},{"issue":"9","key":"1544_CR61","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.2005.049403","volume":"65","author":"D Makrygiannakis","year":"2006","unstructured":"Makrygiannakis D, Af KE, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L et al (2006) Citrullination is an inflammation-dependent process. Ann Rheum Dis 65(9):1219\u20131222","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1544-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1544-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1544-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T23:49:59Z","timestamp":1591746599000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1544-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,5]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1544"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1544-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,5]]}}}